𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression patterns of potential therapeutic targets in prostate cancer

✍ Scribed by Tobias Zellweger; Christoph Ninck; Michael Bloch; Martina Mirlacher; Pasi A. Koivisto; Heikki J. Helin; Michael J. Mihatsch; Thomas C. Gasser; Lukas Bubendorf


Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
681 KB
Volume
113
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Regulatory processes affecting androgen
✍ G. Prem Veer Reddy; Evelyn R. Barrack; Q. Ping Dou; Mani Menon; Ronald Pelley; F πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 281 KB

## Abstract Prostate cancer cells rely on androgen receptor (AR) for proliferation and survival. Therefore, curing prostate cancer will require elimination of AR. Although androgen is the natural ligand that activates AR, AR activity is also subject to regulation by growth factor/growth factor rece

Inactivation of Id-1 in prostate cancer
✍ Xiaomeng Zhang; Ming-Tat Ling; Xianghong Wang; Y.C. Wong πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 942 KB

## Abstract Resistance to anticancer drugs is the major problem in the treatment of many advanced cancers, including androgen‐independent prostate cancer. Recently, increased expression of Id‐1, a basic helix‐loop‐helix protein, is reported in several types of advanced cancer. It is suggested that

Increase of AKT/PKB expression correlate
✍ Yongde Liao; Rainer Grobholz; Ulrich Abel; Lutz Trojan; Maurice Stephan Michel; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 220 KB

AKT/PKB is a central signaling molecule related to stimulation of cell proliferation and inhibition of apoptosis. Perturbations of AKT expression and function play an important role in tumor development and progression. We wanted to determine (a) whether AKT is overexpressed in human prostatic tumor